Indian drugmaker Sun Pharmaceutical Industries together with its subsidiaries announced that further to its intimation dated ...

New World Health Organisation (WHO) recommendations for the use of long-acting HIV prevention and treatment are a welcome boost in the global efforts to end ...

ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...

The Delhi High Court has declined a plea moved by US-based Kroll Information Assurance, seeking to patent 'System to locate ...

New Delhi: Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment ...

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...

Aurobindo Pharma will manufacture & supply long-acting injectable HIV treatment cabotegravir across 133 countries, including ...

Aurobindo Pharma to manufacture and supply long-acting injectable HIV treatment in 133 countries, offering alternative to ...

Investing.com -- Ericsson (ST: ERICb) on Tuesday reported a net profit of SEK 4.6 billion in the second quarter of 2025, reversing a SEK 11 billion loss in the same period last year. The turnaround ...